Posted inMarket
Raymond James Lowers Dycom Industries Price Target Amid Guidance Worries
Discover why Raymond James reduced its stock price target for Dycom Industries following recent financial guidance updates and market concerns.
Posted inMarket
Baird Increases Climb Bio Stock Price Target Following Trial Data
Financial firm Baird has raised its price target for Climb Bio stock to $25 following recent clinical trial data updates.
